Enalapril vs Mirvetuximab Soravtansine

## Enalapril vs Mirvetuximab Soravtansine: Overview

This comparison examines the pharmacological differences between **Enalapril** and **Mirvetuximab Soravtansine**.

## Mechanism of Action

**Enalapril**: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

## Pharmacokinetics

**Half-life**: Enalapril — 11 hours; Mirvetuximab Soravtansine — N/A.

## Chemical Properties

**Molecular Formula**: Enalapril — C20H28N2O5; Mirvetuximab Soravtansine — N/A.

**Molecular Weight**: Enalapril — 376.4470 g/mol; Mirvetuximab Soravtansine — N/A.

**Type**: Enalapril — Small molecule; Mirvetuximab Soravtansine — Antibody drug conjugate.